VANTAGE Surgical Solutions’ Post

It’s #MSKMonday and I am here to talk about the public ortho markets. DePuy Synthes, as part of Johnson & Johnson MedTech was one of the first to kick-off Q2 earnings reporting season which will see many of its peers reading out in the coming several weeks, some as late as early August. DePuy reported 2.1% sales growth relative to Q2 of last year, and 3.2% compared to the prior period. https://lnkd.in/e5NbXxDM  On the one hand – we are likely through the post-covid bolus and the massive growth rates we have seen over the last several years will likely subside. On the other hand, some of DePuy’s closest peers, have been posting high single digit, and some (we won’t name names but we all know who) even hitting double digit growth. So in the coming weeks – where these peers land will show whether the whole market is cooling off equally, or whether we are continuing to see share shifts in a historical oligopoly market. Zimmer Biomet Stryker Smith+Nephew Enovis What will we see in the spine market where mergers have re-shaped the field? Where profitability has been impossible to come by as distributors continue to wield outsize power in access to surgeons? Globus Medical Alphatec Spine SeaSpine Medtronic Will big bets like Globus Medical’s Excelsius approval in TKA and its new knee system pay off by making a dent? https://lnkd.in/eyvuSdg5 Keep your eyes and ears peeled…

Lincotek Medical: Pioneering a Transformation into a Comprehensive Solution Provider We are proud to present an in-depth examination of Lincotek Medical's strategic evolution, marking a significant pivot towards becoming an integrated solution provider within the orthopedic sector. Guided by the visionary foresight of our founder, Nelso Antolotti, Lincotek Medical has consistently harnessed technology and innovation to better serve our clients' diverse needs. Our transition from a global contract manufacturer to a comprehensive solution provider reflects our commitment to trully support orthopedic companies, the preservation of our family culture, and our focus on sustainable, long-term achievements for us and our partners. Facing the intricacies of global expansion, we remain steadfast in delivering unparalleled support, consultancy, and product solutions, thereby enhancing the value we offer to our clients. This article delves into how Lincotek Medical sustains its foundational values amidst global scaling, the role of our family-oriented approach in shaping our company's future, and the strategic initiatives we are implementing to assist orthopedic companies, optimize manufacturing processes, and ensure global regulatory compliance. Read the full article: https://lnkd.in/dagEj5UH #Lincotek #SolutionProvider #CDMO #Orthopedics #IntegratedSolutions #OrthopedicManufacturing

When it comes to an ambulatory surgery center (ASC), having the right group purchasing organization (GPO) can make all the difference. Learn more about how GPOs can help reduce operating costs. https://lnkd.in/g8k7CWgT

𝐄𝐧𝐝𝐨𝐬𝐜𝐨𝐩𝐲 𝐄𝐪𝐮𝐢𝐩𝐦𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $46.2 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2029 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞: https://lnkd.in/dv9tCjNq The global endoscopy equipment market in terms of revenue was estimated to be worth $32.3 billion in 2024 and is poised to reach $46.2 billion by 2029, growing at a CAGR of 7.4% from 2024 to 2029. The growth in the market can be attributed to the factors, including increasing investments, funds, and grants by governments and other organizations, rising focus of hospitals to expand endoscopic units and bring advancements in endoscopic technologies. At the same time, high overhead costs of endoscopy procedures with limited reimbursement in emerging economies can restrain the growth of this market during the forecast period. 𝐃𝐫𝐢𝐯𝐞𝐫𝐬: 1. Growing focus of hospitals to invest in technologically advanced endoscopy instruments and expand endoscopy units 𝐎𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬: 1. Booming healthcare sector in developing economies 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Olympus Corporation KARL STORZ Boston Scientific Johnson & Johnson Stryker Medtronic FUJIFILM Holdings America Corporation Hoya Nipro Medical Corporation Smith+Nephew Intuitive Surgical Ltd Richard Wolf GmbH Cook Medical BKK B. Braun Melsungen AG CONMED Corporation Ambu A/S CapsoVision, Inc. Fortimedix Surgical B.V. THE COOPER COMPANIES GLOBAL HOLDINGS LP LABORIE MEDICAL TECHNOLOGIES EUROPE Teleflex Webmaster Carl Zeiss Meditec AG Dantschke Medizintechnik GmbH & Co. KG Arthrex

United States Endoscopy Devices Market Expected to Reach US$ 17.41 Billion by 2030 with J&J, Stryker, Boston Scientific, CONMED, Medtronic, Fujifilm, & Smith and Nephew Leading - ResearchAndMarkets.com DUBLIN--(BUSINESS WIRE)--The "United States Endoscopy Devices Market, Size, Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Opportunity Companies Analysis" report has been added to ResearchAndMarkets.com's offering. The report presents an in-depth analysis of the United States Endoscopy Devices Market, revealing an anticipated market value of approximately US$ 17.41 Billion by the year 2030. via Business Wire Health: Medical Devices News April 23, 2024 at 07:26PM

Suture Laparoscopic Forceps Global Market Report 2024 - By Demand, Growth, Trends, Share, Forecast To 2033 | Johnson & Johnson, Medtronic plc, Stryker Corporation For more Info: https://lnkd.in/gtryz8MV https://lnkd.in/gvd4Prgj #marketresearch #marketintelligence #marketreport #industryanalysis #TheBusinessResearchCompany #TBRC #GlobalMarketModel

Today, we’re bringing you acquisition, FDA, and technology news for your Tuesday morning.   Stryker has completed its acquisition of SERF SAS, a French joint replacement company, from Menix. This acquisition strengthens Stryker's presence in Europe and expands its global joint replacement portfolio, aiming to offer a wider range of patient-enhanced implant options. With over 50 years of expertise, SERF SAS is known for innovations like the Dual Mobility Cup. Mathieu Badard, VP and GM of Stryker's Joint Replacement division in Europe, expressed excitement about merging portfolios to increase patient access to cutting-edge joint replacement solutions.   https://lnkd.in/gqF6T4Kb   The FDA announced that Abiomed is updating the instructions for use (IFU) of its Impella Left Sided Blood Pumps due to the risk of pump catheters perforating the left ventricle wall, potentially causing serious injuries or death, with 129 reported serious injuries and 49 deaths so far. The affected products include Impella 2.5, Impella CP, Impella CP with SmartAssist, Impella 5.0, Impella 5.5 with SmartAssist, and Impella LD. Adverse effects may include left ventricle perforation, hypertension, lack of blood flow, and death. Abiomed issued an Urgent Medical Device Correction letter on December 27, 2023, instructing affected customers to follow new warnings and procedures, such as careful positioning of the pump catheter during procedures, using imaging during catheter advancement, special care in high-risk patients or during CPR, reviewing updated IFU warnings, and informing relevant personnel and facilities.   https://lnkd.in/gFkS38jT   Researchers at the The University of Queensland, led by Professor Jason Roberts, conducted a study on accelerated antibiotic effectiveness for sepsis patients in ICUs using dosing software in the DIRECT study. Patients received efficient treatment in half the time, leading to quicker recovery, improved care quality, cost savings, and increased bed availability. By swiftly identifying bacteria and tailoring doses, the team reduced ICU stays and expenses, benefiting both adults and children across four Brisbane hospitals. Associate Professor Adam Irwin highlighted the study's significance in enhancing infection treatment accuracy, supported by funding from MRFF Rapid Applied Research Translation Programme Grants. Published in Intensive Care Medicine, the research promises better outcomes for critically ill patients.   https://lnkd.in/gB8-3ide #MedTechNews #MedicalDevices #HealthcareInnovation #MedTechIndustry #HealthTech #HealthcareTechnology #MedDeviceNews #HealthcareNews #MedTechTrends

Endoscopy Equipment Market worth $46.2 billion by 2029 Download PDF Brochure:-https://lnkd.in/dmBdqKmC The global endoscopy equipment market in terms of revenue was estimated to be worth $32.3 billion in 2024 and is poised to reach $46.2 billion by 2029, growing at a CAGR of 7.4% from 2024 to 2029. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Olympus Corporation KARL STORZ Boston Scientific Johnson & Johnson Stryker Medtronic, FUJIFILM Holdings Corporation Hoya Nipro Corporation - Global Smith+Nephew Intuitive, Richard Wolf GmbH Cook Medical BKK B. Braun Melsungen AG CONMED Corporation Ambu A/S CapsoVision, Inc. Fortimedix Surgical B.V. THE COOPER COMPANIES GLOBAL HOLDINGS LP, Teleflex ZEISS Group Dantschke Medizintechnik GmbH & Co. KG Arthrex. #endoscopy #medicaldevices #healthcaretechnology #minimallyinvasivesurgery #gastroenterology

Endoscopy Equipment Market worth $46.2 billion by 2029 Download PDF Brochure:-https://lnkd.in/d45S39zc The global endoscopy equipment market in terms of revenue was estimated to be worth $32.3 billion in 2024 and is poised to reach $46.2 billion by 2029, growing at a CAGR of 7.4% from 2024 to 2029. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Olympus Corporation KARL STORZ Boston Scientific Johnson & Johnson Stryker Medtronic, FUJIFILM Holdings Corporation Hoya Nipro Corporation - Global Smith+Nephew Intuitive, Richard Wolf GmbH Cook Medical BKK B. Braun Melsungen AG CONMED Corporation Ambu A/S CapsoVision, Inc. Fortimedix Surgical B.V. THE COOPER COMPANIES GLOBAL HOLDINGS LP, Teleflex ZEISS Group Dantschke Medizintechnik GmbH & Co. KG Arthrex. #endoscopy #medicaldevices #healthcaretechnology #minimallyinvasivesurgery #gastroenterology